Delivery Order SPE2DR25D6028-SPE2DR26FATDA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,414.38 to AmerisourceBergen Drug Corp for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication. The contract was competitively awarded on December 5, 2025, with an ultimate completion date of December 8, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order for levothyroxine sodium to AmerisourceBergen Drug Corp on December 22, 2025, with a ceiling value of $2,962.37 and an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone used to treat hypothyroidism and other thyroid conditions. This firm fixed price delivery order has a ceiling value of $1,801.64 and is scheduled for completion by October 20, 2025. The contract was awarded without a set-aside designation through competitive procurement, with performance taking place at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 30, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,723.68 with an ultimate completion date of September 2, 2025, represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Levothyroxine 200 micrograms, valued at $1,047.02 under a firm fixed-price contract type. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025. This is an unset-aside competitive award, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Levothyroxine is a synthetic thyroid hormone commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Levothyroxine 200 mcg tablets in quantities of 1,000 units, with a ceiling value of $13,837.62. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for ultimate completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Levothyroxine 100 mcg/ml vials under a firm fixed-price contract valued at $2,015.19, with completion expected by October 20, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction within...
- The Defense Logistics Agency Troop Support Medical awarded a $106,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500mg levothyroxine sodium tablets. As the prime contractor, Amerisourcebergen will deliver 120 tablets to a facility in Conshohocken, Pennsylvania under a one-day period of performance starting August 14, 2023 and concluding on August 15, 2023. The ordering agency, DLA Troop Support Medical, supports the Department of Defense by procuring...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.66 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 137 mcg tablets (100-count units) with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on July 21, 2025. The contractor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $11,490 delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of 100 microgram Levothyroxine tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning from July 28 to July 31, 2023. Levothyroxine is a prescription medication used to treat an underactive thyroid. This delivery order was issued against an existing DLA pharmaceutical supply contract...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATDADelivery Order
The Defense Logistics Agency awarded a $2,537.05 delivery order to AmerisourceBergen Drug Corp for levothyroxine sodium on December 29, 2025, with an ultimate completion date of January 27, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Levothyroxine sodium is a synthetic thyroid hormone commonly used to treat hypothyroidism and is a critical pharmaceutical supply for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.9 billion prime vendor agreement valued through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp leverages this IDC vehicle to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's extensive federal contract history demonstrates proven capability to meet competitive procurement requirements and deliver diverse medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/28/25 |